ADQ to Acquire Turkish Pharmaceuticals Company Birgi Mefar

​United Arab Emirates' sovereign investment fund ADQ announced that it has entered into a definitive agreement to acquire Turkish pharmaceuticals company Birgi Mefar Group (BMG).

Commenting on the deal, Fahad Al Qassim, Executive Director at ADQ said, “Türkiye is an important market for our investments, and BMG brings with it a strong presence throughout the pharmaceutical supply chain, from drug development and manufacturing to packaging and cold chain distribution."

“Joining ADQ's portfolio is an exciting next step in our journey that will elevate our offering and enable us to scale in lucrative markets like the UAE and wider MENA region," Faik Somer, CEO at Birgi Mefar Group, underlined in the press release.

Birgi Mefar Group (BMG) is one of Türkiye's leading manufacturers of sterile injectable products, with an export base spanning more than 30 countries, including European and Asian markets.

" src=
ADQ; pharmaceuticals; Birgi Mefar Group; acquisition